tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ProQR Therapeutics reports Q2 EPS (EUR 0.21) vs. (EUR 0.13) last year
PremiumThe FlyProQR Therapeutics reports Q2 EPS (EUR 0.21) vs. (EUR 0.13) last year
2M ago
ProQR Therapeutics sees cash runway into mid-2027
Premium
The Fly
ProQR Therapeutics sees cash runway into mid-2027
2M ago
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
Premium
The Fly
ProQR Therapeutics price target raised to $5 from $4 at Evercore ISI
3M ago
ProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
PremiumRatingsProQR’s Innovative RNA Editing Platform and Promising AX-0810 Program Drive Buy Rating
5M ago
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
Premium
Company Announcements
ProQR Reports Q1 2025 Financial Results Amid Rising R&D Costs
5M ago
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
Premium
The Fly
ProQR Therapeutics reports Q1 EPS (EUR 0.10) vs (EUR 0.09) last year
5M ago
ProQR Announces New CFO and CMO to Drive Growth
PremiumCompany AnnouncementsProQR Announces New CFO and CMO to Drive Growth
6M ago
ProQR Therapeutics appoints Hom as CFO, Lopez as CMO
Premium
The Fly
ProQR Therapeutics appoints Hom as CFO, Lopez as CMO
6M ago
ProQR Therapeutics Advances RNA Editing Pipeline
Premium
Company Announcements
ProQR Therapeutics Advances RNA Editing Pipeline
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100